
MorphoSys AG MOR
Annual report 2023
added 12-13-2025
MorphoSys AG ROA Ratio 2011-2025 | MOR
Annual ROA Ratio MorphoSys AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -20.13 | 5.9 | -20.75 | -10.43 | -16.81 | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.9 | -20.75 | -12.44 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
-50.45 | $ 4.85 | 3.03 % | $ 805 M | ||
|
Aclaris Therapeutics
ACRS
|
-59.94 | $ 3.24 | -0.46 % | $ 250 M | ||
|
AlloVir
ALVR
|
-49.57 | - | 4.14 % | $ 49.1 M | ||
|
Aptevo Therapeutics
APVO
|
-154.77 | $ 1.06 | -6.19 % | $ 293 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
-35.36 | $ 216.6 | -1.74 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.14 | -4.56 % | $ 7.55 B | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
BioVie
BIVI
|
-81.36 | $ 1.37 | -5.21 % | $ 2.02 M | ||
|
ARCA biopharma
ABIO
|
-21.14 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
-13.29 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-40.29 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
65.02 | $ 93.82 | -1.04 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-34.19 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
10.11 | $ 26.28 | 3.99 % | $ 1.27 B | ||
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
-30.55 | $ 9.56 | - | $ 140 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-86.4 | $ 0.27 | -7.19 % | $ 588 M | ||
|
Arena Pharmaceuticals
ARNA
|
-78.56 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
-144.48 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | ||
|
Catalyst Biosciences
CBIO
|
-73.35 | $ 13.75 | -2.41 % | $ 905 M | ||
|
Avenue Therapeutics
ATXI
|
-437.72 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
8.43 | $ 545.68 | -3.3 % | $ 41.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-10.92 | $ 2.37 | 3.04 % | $ 14.9 M | ||
|
AstraZeneca PLC
AZN
|
0.11 | $ 91.17 | 1.49 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
5.51 | $ 8.9 | -1.22 % | $ 1.45 B | ||
|
BeiGene, Ltd.
BGNE
|
-10.89 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-78.59 | $ 11.36 | -1.52 % | $ 735 M | ||
|
Biogen
BIIB
|
5.82 | $ 173.96 | -0.08 % | $ 25.3 B | ||
|
Abeona Therapeutics
ABEO
|
-84.67 | $ 5.09 | -5.13 % | $ 109 M | ||
|
Celldex Therapeutics
CLDX
|
-19.92 | $ 27.29 | -0.8 % | $ 1.76 M | ||
|
ADiTx Therapeutics
ADTX
|
-125.54 | $ 1.65 | -26.34 % | $ 21.7 K | ||
|
Cellectar Biosciences
CLRB
|
-354.19 | $ 3.41 | -5.8 % | $ 41.7 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-104.83 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-43.36 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
-289.96 | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
2.66 | - | - | - | ||
|
Фармсинтез
LIFE
|
-25.57 | - | - | - |